These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26106624)

  • 1. Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications.
    Rajasekar P; O'Neill CL; Eeles L; Stitt AW; Medina RJ
    J Diabetes Res; 2015; 2015():436879. PubMed ID: 26106624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Contribution to the Development and Progression of Vascular Diabetic Complications.
    Rodriguez H; El-Osta A
    Antioxid Redox Signal; 2018 Oct; 29(11):1074-1091. PubMed ID: 29304555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation in diabetic vascular complications.
    Jin J; Wang X; Zhi X; Meng D
    J Mol Endocrinol; 2019 Nov; 63(4):R103-R115. PubMed ID: 31600719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms.
    Tonna S; El-Osta A; Cooper ME; Tikellis C
    Nat Rev Nephrol; 2010 Jun; 6(6):332-41. PubMed ID: 20421885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: the role of epigenetics in the metabolic memory of diabetic complications.
    Chen Z; Malek V; Natarajan R
    Am J Physiol Renal Physiol; 2024 Sep; 327(3):F327-F339. PubMed ID: 38961840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Karma-The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture.
    Cooper ME; El-Osta A; Allen TJ; Watson AMD; Thomas MC; Jandeleit-Dahm KAM
    Diabetes; 2018 May; 67(5):785-790. PubMed ID: 29678824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of epigenetic mechanisms in the vascular complications of diabetes.
    Reddy MA; Natarajan R
    Subcell Biochem; 2013; 61():435-54. PubMed ID: 23150262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human aortic endothelium undergoes dose-dependent DNA methylation in response to transient hyperglycemia.
    Pepin ME; Schiano C; Miceli M; Benincasa G; Mansueto G; Grimaldi V; Soricelli A; Wende AR; Napoli C
    Exp Cell Res; 2021 Mar; 400(2):112485. PubMed ID: 33515594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Mechanisms in Diabetic Vascular Complications and Metabolic Memory: The 2020 Edwin Bierman Award Lecture.
    Natarajan R
    Diabetes; 2021 Feb; 70(2):328-337. PubMed ID: 33472942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic mechanisms in diabetic vascular complications.
    Reddy MA; Natarajan R
    Cardiovasc Res; 2011 Jun; 90(3):421-9. PubMed ID: 21266525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possible participation of advanced glycation endproducts and their receptor system in the development of diabetic vascular complications].
    Yamamoto Y; Sakurai S; Watanabe T; Yonekura H; Yamamoto H
    Nihon Yakurigaku Zasshi; 2003 Jan; 121(1):49-55. PubMed ID: 12617038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.
    Szabo C
    Br J Pharmacol; 2009 Mar; 156(5):713-27. PubMed ID: 19210748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications.
    Papachristoforou E; Lambadiari V; Maratou E; Makrilakis K
    J Diabetes Res; 2020; 2020():7489795. PubMed ID: 33123598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic retinopathy, metabolic memory and epigenetic modifications.
    Kowluru RA
    Vision Res; 2017 Oct; 139():30-38. PubMed ID: 28700951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs: potential mediators and biomarkers of diabetic complications.
    Kato M; Castro NE; Natarajan R
    Free Radic Biol Med; 2013 Sep; 64():85-94. PubMed ID: 23770198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic study of endothelial dysfunction induced by AGEs and its possible role in diabetic cardiovascular complications.
    Banarjee R; Sharma A; Bai S; Deshmukh A; Kulkarni M
    J Proteomics; 2018 Sep; 187():69-79. PubMed ID: 29935336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers.
    Catrina SB; Zheng X
    Diabetes Metab Res Rev; 2016 Jan; 32 Suppl 1():179-85. PubMed ID: 26453314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics: mechanisms and implications for diabetic complications.
    Cooper ME; El-Osta A
    Circ Res; 2010 Dec; 107(12):1403-13. PubMed ID: 21148447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of sulphoraphane against vascular complications in diabetes.
    Yamagishi S; Matsui T
    Pharm Biol; 2016 Oct; 54(10):2329-39. PubMed ID: 26841240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC; Burlina S; Lapolla A
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.